Sagimet Biosciences Statistics
Total Valuation
SGMT has a market cap or net worth of $98.61 million. The enterprise value is -$95.07 million.
Market Cap | 98.61M |
Enterprise Value | -95.07M |
Important Dates
The next estimated earnings date is Monday, August 19, 2024, after market close.
Earnings Date | Aug 19, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SGMT has 31.91 million shares outstanding. The number of shares has increased by 15,585.37% in one year.
Shares Outstanding | 31.91M |
Shares Change (YoY) | +15,585.37% |
Shares Change (QoQ) | +177.61% |
Owned by Insiders (%) | 14.28% |
Owned by Institutions (%) | 76.28% |
Float | 15.94M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 49.31 |
Forward PS | n/a |
PB Ratio | 0.52 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 43.12, with a Debt / Equity ratio of 0.00.
Current Ratio | 43.12 |
Quick Ratio | n/a |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -61.90% and return on invested capital (ROIC) is -17.23%.
Return on Equity (ROE) | -61.90% |
Return on Assets (ROA) | -26.90% |
Return on Capital (ROIC) | -17.23% |
Revenue Per Employee | $200,000 |
Profits Per Employee | -$2.79M |
Employee Count | 10 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -80.75% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -80.75% |
50-Day Moving Average | 4.21 |
200-Day Moving Average | 5.31 |
Relative Strength Index (RSI) | 37.76 |
Average Volume (20 Days) | 590,736 |
Short Selling Information
The latest short interest is 2.28 million, so 7.14% of the outstanding shares have been sold short.
Short Interest | 2.28M |
Short Previous Month | 2.26M |
Short % of Shares Out | 7.14% |
Short % of Float | 14.29% |
Short Ratio (days to cover) | 3.12 |
Income Statement
In the last 12 months, SGMT had revenue of $2.00 million and -$27.92 million in losses. Loss per share was -$38.69.
Revenue | 2.00M |
Gross Profit | 2.00M |
Operating Income | -32.74M |
Pretax Income | -27.92M |
Net Income | -27.92M |
EBITDA | -27.78M |
EBIT | -27.92M |
Loss Per Share | -$38.69 |
Balance Sheet
The company has $193.71 million in cash and $26,000 in debt, giving a net cash position of $193.68 million or $6.07 per share.
Cash & Cash Equivalents | 193.71M |
Total Debt | 26,000 |
Net Cash | 193.68M |
Net Cash Per Share | $6.07 |
Equity (Book Value) | 190.02M |
Book Value Per Share | 5.95 |
Working Capital | 189.98M |
Cash Flow
Operating Cash Flow | -22.89M |
Capital Expenditures | n/a |
Free Cash Flow | -22.89M |
FCF Per Share | -$0.79 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,637.15% and -1,395.90%.
Gross Margin | 100.00% |
Operating Margin | -1,637.15% |
Pretax Margin | -1,395.90% |
Profit Margin | -1,395.90% |
EBITDA Margin | -1,388.85% |
EBIT Margin | -1,395.90% |
FCF Margin | -1,144.50% |
Dividends & Yields
SGMT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15,585.37% |
Shareholder Yield | -15,585.37% |
Earnings Yield | -28.31% |
FCF Yield | -23.21% |
Analyst Forecast
The average price target for SGMT is $35.80, which is 1,058.58% higher than the current price. The consensus rating is "Buy".
Price Target | $35.80 |
Price Target Difference | 1,058.58% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 116.53% |
EPS Growth Forecast (5Y) | 13.61% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SGMT has an Altman Z-Score of 11.98 and a Piotroski F-Score of 2.
Altman Z-Score | 11.98 |
Piotroski F-Score | 2 |